Annexon to Present Additional Phase 2 Data Showing
Protective Effects of ANX007 on Visual Acuity and Vision Related Anatomical Measures in the Central Macula Will be Presented as ...
Read more
ADVERTISEMENT
ADVERTISEMENT
Tag: annexon
Annexon Presented Additional Positive Phase 3 Results for
ANX005-Treated Patients Demonstrated Faster and More Complete Recovery from Week 1 through Week 26 on Primary and Multiple Pre-Specified Endpoints ...
Read moreAnnexon Announces Pricing of $125 Million Underwritten
BRISBANE, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform ...
Read moreAnnexon Announces Proposed Public Offering of Common Stock
BRISBANE, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform ...
Read moreAnnexon Biosciences to Host Conference Call and Webcast to
BRISBANE, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class ...
Read moreAnnexon Outlines 2024 Priorities with Late-Stage Clinical
ANX005 Phase 3 Pivotal Data in Guillain-Barré Syndrome (GBS) On Track for First Half of 2024;Potential to be First Approved ...
Read moreAnnexon Biosciences to Present at the 42nd Annual J.P.
BRISBANE, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX) a clinical-stage biopharmaceutical company developing a new class ...
Read moreAnnexon Reports Phase 1 Results for ANX1502, its Oral Small
Target Levels of Active Drug Achieved in Healthy Volunteers with Oral Twice-Daily Dosing; Supportive Impact on Pharmacodynamic Biomarker of Complement Activity ...
Read moreAnnexon Outlines Global Registrational Program for ANX007
Alignment with FDA on Best Corrected Visual Acuity ≥ 15-Letter Loss as Primary Outcome Measure - Representing the Highest Value ...
Read moreAnnexon Announces Pricing of $125.0 Million Underwritten
BRISBANE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Annexon, Inc. (NASDAQ: ANNX), a clinical-stage biopharmaceutical company developing a new class ...
Read more
LifeCare News is a registered magazine in RNI (Registrar of Newspapers for India) is started in 2015, as well as Lifecarenews have a malti language portal. Life Care News portal was connected with many reputed news agency.